Skip to main content
Log in

Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Helicobacter pylori infection (HPI) imposes substantial social costs and is of major etiological importance in peptic ulcer disease, gastric cancer, and accelerated cardiovascular diseases. This study determined the risk of acute coronary syndrome (ACS) associated with HPI in a nationwide retrospective cohort study. By using the Taiwan National Health Insurance Research Database (NHIRD), we identified patients diagnosed with HPI from 1998 to 2010. In addition, we randomly selected non-HPI controls frequency-matched by age, sex, and index year from the general population free of HPI. The risk of ACS was analyzed using Cox proportional hazards regression models in which sex, age, and comorbidities were included as variables. We identified 17,075 participants for the HPI group and selected 68,300 participants for the comparison group. The incidence rates were increased in the patients in the HPI group compared with those in the comparison group. Overall, the HPI patients exhibited a 1.93-fold high crude hazard ratio for ACS, and a 1.48-fold adjusted hazard ratio after age, sex, and comorbidities were adjusted. However, the overall adjusted hazard ratio of ACS increased with increasing age with a 3.11 to 8.24 adjusted hazard ratio among the various age groups. Several comorbidities, such as diabetes, hyperlipidemia, and COPD exhibited synergistic effects for ACS risk. We determined a significant association between ACS and comorbidities and provide evidence to encourage clinicians to observe ACS-related comorbidities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Directorate-General of Budget, Accounting and Statistics Executive Yuan, Republic of China (2010) Statistical yearbook of the Republic of China. Health 114

  2. Lin YS, Liu PH, Wu LS, Chen YM, Chang CJ, Chu PH (2014) Major adverse cardiovascular events in adult congenital heart disease: a population-based follow-up study from Taiwan. BMC Cardiovasc Disord 14:38

    Article  PubMed  PubMed Central  Google Scholar 

  3. Chang KC, Tseng MC (2003) Costs of acute care of first-ever ischemic stroke in Taiwan. Stroke 34:e219–e221

    Article  PubMed  Google Scholar 

  4. Regnström J, Jovinge S, Båvenholm P, Ericsson CG, De Faire U, Hamsten A et al (1998) Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease. J Intern Med 243:109–13

    Article  PubMed  Google Scholar 

  5. Ongey M, Brenner H, Thefeld W, Rothenbacher D (2004) Helicobacter pylori and hepatitis a virus infections and the cardiovascular risk profile in patients with diabetes mellitus: results of a population-based study. Eur J Cardiovasc Prev Rehabil 11:471–476

    Article  PubMed  Google Scholar 

  6. Lu YH, Yen HW, Lin TH, Huang CH, Lee KT, Wang WM et al (2002) Changes of coronary risk factors after eradication of Helicobacter pylori infection. Kaohsiung J Med Sci 18:266–272

    PubMed  Google Scholar 

  7. Hara K, Morita Y, Kamihata H, Iwasaka T, Takahashi H (2001) Evidence for infection with Helicobacter pylori in patients with acute myocardial infarction. Clin Chim Acta 313:87–94

    Article  CAS  PubMed  Google Scholar 

  8. Mair J, Jaffe AS (2014) Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice? Mol Diagn Ther 18:5–15

    Article  CAS  PubMed  Google Scholar 

  9. Wang Y, Wang GZ, Rabinovitch PS, Tabas I (2014) Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages. Circ Res 114:421–433

    Article  CAS  PubMed  Google Scholar 

  10. Grufman H, Gonçalves I, Edsfeldt A, Nitulescu M, Persson A, Nilsson M et al (2014) Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques. J Intern Med 275:127–133

    Article  CAS  PubMed  Google Scholar 

  11. Khan S, Rahman HN, Okamoto T, Matsunaga T, Fujiwara Y, Sawa T et al (2014) Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses. Sci Rep 4:4680

    Article  PubMed  PubMed Central  Google Scholar 

  12. Pounder RE, Ng D (1995) The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 9:33–40

    PubMed  Google Scholar 

  13. Brown LM (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22:283–97

    Article  CAS  PubMed  Google Scholar 

  14. Axon AT (2007) Relationship between Helicobacter pylori gastritis, gastric cancer and gastric acid secretion. Adv Med Sci 52:55–60

    CAS  PubMed  Google Scholar 

  15. Kowalski M, Pawlik M, Konturek JW, Konturek SJ (2006) Helicobacter pylori infection in coronary artery disease. J Physiol Pharmacol 57:101–111

    PubMed  Google Scholar 

  16. Elizalde JI, Gómez J, Panés J, Lozano M, Casadevall M, Ramírez J et al (1997) Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 100:996–1005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D et al (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437–439

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M (1996) Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart 75:568–572

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Danesh J, Peto R (1998) Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 316:1130–1132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N et al (1995) Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311:711–714

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Sung KC, Rhee EJ, Ryu SH, Beck SH (2005) Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults. Int J Cardiol 102:411–417

    Article  PubMed  Google Scholar 

  22. Rahman MA, Cope MB, Sarker SA, Garvey WT, Chaudhury HS, Khaled MA (2009) Helicobacter pylori infection and inflammation: implication for the pathophysiology of diabetes and coronary heart disease in Asian Indians. J Life Sci 1:45–50

    PubMed  PubMed Central  Google Scholar 

  23. Rogha M, Dadkhah D, Pourmoghaddas Z, Shirneshan K, Nikvarz M, Pourmoghaddas M (2012) Association of helicobacter pylori infection with severity of coronary heart disease. ARYA Atheroscler 7:138–41

  24. Hussell T, Isaacson PG, Crabtree JE, Spencer J (1996) Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 178:122–127

  25. Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS (2003) Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 71:1755–1762

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM Jr (2004) Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 189:1914–1920

    Article  CAS  PubMed  Google Scholar 

  27. Algood HM, Gallo-Romero J, Wilson KT, Peek RM Jr, Cover TL (2007) Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol 51:577–586

    Article  CAS  PubMed  Google Scholar 

  28. Tamer GS, Tengiz I, Ercan E, Duman C, Alioglu E, Turk UO (2009) Helicobacter pylori seropositivity in patients with acute coronary syndromes. Dig Dis Sci 54:1253–1256

    Article  PubMed  Google Scholar 

  29. Eskandarian R, Ghorbani R, Shiyasi M, Momeni B, Hajifathalian K, Madani M (2012) Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study. Cardiovasc J Afr 23:131–135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Eskandarian R, Malek M, Mousavi SH, Babaei M (2006) Association of Helicobacter pylori infection with cardiac syndrome X. Singapore Med J 47:704–706

    CAS  PubMed  Google Scholar 

  31. Kowalski M, Rees W, Konturek PC, Grove R, Scheffold T, Meixner H et al (2002) Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 34:398–402

    Article  CAS  PubMed  Google Scholar 

  32. Longo-Mbenza B, Ngoma DV, Nahimana D, Mayuku DM, Fuele SM, Ekwanzala F et al (2008) Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa. Eur J Cardiovasc Prev Rehabil 15:503–508

    Article  PubMed  Google Scholar 

  33. Longo-Mbenza B, Nsenga JN, Mokondjimobe E, Gombet T, Assori IN, Ibara JR et al (2012) Helicobacter pylori infection is identified as a cardiovascular risk factor in central Africans. Vasc Health Risk Manag 6:455–461

    Article  PubMed  Google Scholar 

  34. D'Ugo E, Rossi S, De Caterina R (2012) Proton pump inhibitors and clopidogrel: an association to avoid? G Ital Cardiol (Rome) 13:817–826

  35. Marshall B, Stenström B, Mendis A (2008) Helicobacter pylori: the latest in diagnosis and treatment. Aust Fam Physician 37(8):608

    PubMed  Google Scholar 

  36. Budzyński J, Koziński M, Kłopocka M, Kubica JM, Kubica J (2014) Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence. Clin Res Cardiol 1–32

  37. Fan C-T, Lin J-C, Lee C-H (2008) Taiwan Biobank: a project aiming to aid Taiwan’s transition into a biomedical island. Pharmacogenomics 9(2):235–246

Download references

Acknowledgments

This work was supported by grants from the China Medical University (CMU102-BC-2), Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), Health and Welfare Surcharge of Tobacco Products, and the China Medical University Hospital Cancer Research Center of Excellence (MOHW103-TD-B-111-03, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflict of interest

The authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C.-H. Kao.

Additional information

Ching-Yuan Lai and Tse-Yen Yang contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lai, CY., Yang, TY., Lin, CL. et al. Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study. Eur J Clin Microbiol Infect Dis 34, 69–74 (2015). https://doi.org/10.1007/s10096-014-2207-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-014-2207-7

Keywords

Navigation